Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (61-70 of 265) with videos related to

Pageof 27
Sort By:
Health Science Reports|September 29, 2022
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approachCarmen Angioletti, Egidio de Mattia, Luca M Carloni, et al.
Journal of Geriatric Oncology|July 7, 2019
Neurocognitive evaluation in older adult patients affected by gliomaAntonio Tanzilli, Andrea Pace, Alessandra Fabi, et al.
Clinical Breast Cancer|August 5, 2023
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus PaperMattia Garutti, Linda Cucciniello, Grazia Arpino, et al.
Journal of Neuro-Oncology|March 26, 2013
Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of diseaseStefano Telera, Alessandra Fabi, Andrea Pace, et al.
Tumori|October 8, 2016
Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-upVeronica Villani, Roberta Merola, Antonello Vidiri, et al.
World Neurosurgery|February 25, 2016
Spine Surgery in Patients with Metastatic Breast Cancer: A Retrospective AnalysisStefano Telera, Fabrizio Caroli, Laura Raus, et al.
Therapeutics and Clinical Risk Management|April 4, 2023
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in ItalyGiorgio Lorenzo Colombo, Maria Chiara Valentino, Alessandra Fabi, et al.
Cancers|March 29, 2023
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical SettingsPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.
Future Oncology (London, England)|July 23, 2025
Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendationsGiampaolo Bianchini, Alessandra Fabi, Valentina Guarneri, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Pageof 27

Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Health Science Reports|September 29, 2022
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approachCarmen Angioletti, Egidio de Mattia, Luca M Carloni, et al.
Journal of Geriatric Oncology|July 7, 2019
Neurocognitive evaluation in older adult patients affected by gliomaAntonio Tanzilli, Andrea Pace, Alessandra Fabi, et al.
Clinical Breast Cancer|August 5, 2023
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus PaperMattia Garutti, Linda Cucciniello, Grazia Arpino, et al.
Journal of Neuro-Oncology|March 26, 2013
Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of diseaseStefano Telera, Alessandra Fabi, Andrea Pace, et al.
Tumori|October 8, 2016
Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-upVeronica Villani, Roberta Merola, Antonello Vidiri, et al.
World Neurosurgery|February 25, 2016
Spine Surgery in Patients with Metastatic Breast Cancer: A Retrospective AnalysisStefano Telera, Fabrizio Caroli, Laura Raus, et al.
Therapeutics and Clinical Risk Management|April 4, 2023
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in ItalyGiorgio Lorenzo Colombo, Maria Chiara Valentino, Alessandra Fabi, et al.
Cancers|March 29, 2023
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical SettingsPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.
Future Oncology (London, England)|July 23, 2025
Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendationsGiampaolo Bianchini, Alessandra Fabi, Valentina Guarneri, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.
Pageof 27